Back to Top

Multiple Myeloma

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Fully Allocated – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s Multiple Myeloma fund is currently fully allocated. As of September 20, 2017, Leukemia and Lymphoma Society, Healthwell and Patient Advocate Foundation are accepting applications.

Assistance Amount

$8,400 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for the disease named in the assistance program to which he or she is applying.
  2. The patient must have health insurance that covers his or her qualifying medication or product. 
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Active Injection Kit D (dexamethasone sodium phosphate/pf)
  • Adriamycin (doxorubicin hcl)
  • Alkeran (melphalan)
  • Bendeka (bendamustine hcl)
  • Cisplatin (cisplatin)
  • Cyclophosphamide (cyclophosphamide)
  • Darzalex (daratumumab)
  • Deltasone (prednisone)
  • Dexamethasone (dexamethasone)
  • Dexamethasone Intensol (dexamethasone)
  • Dexamethasone Sodium Phosphate (dexamethasone sod phosphate)
  • Dexamethasone Sodium Phosphate (dexamethasone sodium phosphate/pf)
  • Dexpak (dexamethasone)
  • Doubledex (dexamethasone sodium phosphate/pf)
  • Doxil (doxorubicin hcl pegylated liposomal)
  • Doxorubicin Hcl (doxorubicin hcl)
  • Doxorubicin Hcl Liposome (doxorubicin hcl pegylated liposomal)
  • Empliciti (elotuzumab)
  • Etopophos (etoposide phosphate)
  • Etoposide (etoposide)
  • Evomela (melphalan hcl/betadex sulfobutyl ether sodium)
  • Farydak (panobinostat lactate)
  • Intron A (interferon alfa-2b,recomb.)
  • Kyprolis (carfilzomib)
  • Lipodox (doxorubicin hcl pegylated liposomal)
  • Lipodox 50 (doxorubicin hcl pegylated liposomal)
  • Methotrexate (methotrexate sodium)
  • Ninlaro (ixazomib citrate)
  • Pamidronate Disodium (pamidronate disodium)
  • Pomalyst (pomalidomide)
  • Prednisone (prednisone)
  • Prednisone Intensol (prednisone)
  • Rayos (prednisone)
  • Reclast (zoledronic acid in mannitol and water for injection)
  • Revlimid (lenalidomide)
  • Thalomid (thalidomide)
  • Toposar (etoposide)
  • Treanda (bendamustine hcl)
  • Trexall (methotrexate sodium)
  • Velcade (bortezomib)
  • Vincasar Pfs (vincristine sulfate)
  • Vincristine Sulfate (vincristine sulfate)
  • Zoledronic Acid (zoledronic acid)
  • Zoledronic Acid (zoledronic acid in mannitol and 0.9 % sodium chloride)
  • Zoledronic Acid (zoledronic acid in mannitol and water for injection)
  • Zolinza (vorinostat)
  • Zometa (zoledronic acid)
  • Zometa (zoledronic acid in mannitol and water for injection)

Diagnosis Codes:

ICD-10: C90.00-C90.32